Omics-based profiles and biomarkers of respiratory infections: are we there yet?
Extract From the influenza pandemic of 1918–1919 to the most recent COVID-19 pandemic,
respiratory infections remain a leading cause of mortality worldwide [1, 2]. Concurrently, the …
respiratory infections remain a leading cause of mortality worldwide [1, 2]. Concurrently, the …
[HTML][HTML] Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome
A substantial number of patients recovering from acute SARS-CoV-2 infection present
serious lingering symptoms, often referred to as long COVID (LC). However, a subset of …
serious lingering symptoms, often referred to as long COVID (LC). However, a subset of …
Biomarkers of High Flow Therapy Outcome in COVID-19 pneumonia: a single-center prospective study
T Marin, I Aldas, M Galdeano, E Roca, A Hernandez… - medRxiv, 2024 - medrxiv.org
Patients with acute hypoxemic respiratory failure (AHRF) due to COVID-19 undergoing High
Flow Therapy (HFT) before intubation presented an increased risk of mortality when …
Flow Therapy (HFT) before intubation presented an increased risk of mortality when …
[HTML][HTML] Differences between human male and female neutrophils in mRNA, translation efficiency, protein, and phosphoprotein profiles
Background Human males and females show differences in the incidence of neutrophil-
associated diseases such as systemic lupus erythematosus, rheumatoid arthritis, and …
associated diseases such as systemic lupus erythematosus, rheumatoid arthritis, and …
Proteomic analysis reveals dysregulation of peripheral blood neutrophils in patients with Multiple Sclerosis
Multiple Sclerosis (MS) is a complex auto-inflammatory disease affecting the brain and
spinal cord, which results in axonal de-myelination and symptoms including fatigue, pain …
spinal cord, which results in axonal de-myelination and symptoms including fatigue, pain …
[HTML][HTML] The 10 Buckets of Long Covid Recovery
J Drummond - integrativewomenshealthinstitute …
Unfortunately there are not yet any commercially available biomarkers for viral persistence
for SARS COV2. But, there are multiple studies pointing to viral persistence or viral RNA …
for SARS COV2. But, there are multiple studies pointing to viral persistence or viral RNA …